Larson Financial Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $110K | Buy |
2,166
+336
| +18% | +$15.7K | ﹤0.01% | 949 |
|
|
2025
Q4 | $54K | Sell |
1,830
-305
| -14% | -$8.29K | ﹤0.01% | 1191 |
|
|
2025
Q3 | $55.1K | Sell |
2,135
-343
| -14% | -$9.57K | ﹤0.01% | 1119 |
|
|
2025
Q2 | $68.4K | Sell |
2,478
-106
| -4% | -$2.79K | ﹤0.01% | 963 |
|
|
2025
Q1 | $73.3K | Buy |
2,584
+1,318
| +104% | +$46.8K | ﹤0.01% | 881 |
|
|
2024
Q4 | $52.6K | Buy |
1,266
+356
| +39% | +$17K | ﹤0.01% | 885 |
|
|
2024
Q3 | $60.8K | Buy |
910
+317
| +53% | +$29.1K | ﹤0.01% | 851 |
|
|
2024
Q2 | $70.4K | Buy |
593
+561
| +1,753% | +$71K | ﹤0.01% | 731 |
|
|
2024
Q1 | $3.41K | Hold |
32
| – | – | ﹤0.01% | 1269 |
|
|
2023
Q4 | $3.18K | Sell |
32
-83
| -72% | -$6.98K | ﹤0.01% | 1284 |
|
|
2023
Q3 | $11.9K | Sell |
115
-8
| -7% | -$892 | ﹤0.01% | 951 |
|
|
2023
Q2 | $14.9K | Buy |
123
+4
| +3% | +$534 | ﹤0.01% | 820 |
|
|
2023
Q1 | $18.3K | Hold |
119
| – | – | ﹤0.01% | 763 |
|
|
2022
Q4 | $21.4K | Hold |
119
| – | – | ﹤0.01% | 681 |
|
|
2022
Q3 | $14K | Hold |
119
| – | – | ﹤0.01% | 707 |
|
|
2022
Q2 | $17K | Buy |
119
+8
| +7% | +$1.14K | ﹤0.01% | 583 |
|
|
2022
Q1 | $19K | Sell |
111
-70
| -39% | -$11.8K | ﹤0.01% | 540 |
|
|
2021
Q4 | $46K | Buy |
181
+40
| +28% | +$11.7K | 0.01% | 395 |
|
|
2021
Q3 | $54K | Buy |
141
+40
| +40% | +$14.8K | 0.01% | 283 |
|
|
2021
Q2 | $24K | Sell |
101
-36
| -26% | -$6.43K | 0.01% | 401 |
|
|
2021
Q1 | $18K | Buy |
137
+11
| +9% | +$1.59K | 0.01% | 434 |
|
|
2020
Q4 | $13K | Sell |
126
-1,128
| -90% | -$114K | ﹤0.01% | 456 |
|
|
2020
Q3 | $89K | Sell |
1,254
-298
| -19% | -$20.8K | 0.04% | 137 |
|
|
2020
Q2 | $100K | Buy |
1,552
+1,535
| +9,029% | +$84.1K | 0.05% | 134 |
|
|
2020
Q1 | $1K | Buy |
+17
| New | +$391 | ﹤0.01% | 491 |
|
Other funds holding MRNA
VCM
VPM
